CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04264143 |
|
Recruitment Status :
Recruiting
First Posted : February 11, 2020
Last Update Posted : March 10, 2022
|
Sponsor:
Luca Szalontay
Collaborator:
Midatech Pharma US Inc.
Information provided by (Responsible Party):
Luca Szalontay, Columbia University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 2023 |
| Estimated Study Completion Date : | February 2024 |